← Alle mensen

ER

Eduardo Richardet

3 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Five-year outcomes with first-line nivolumab plus ipilimumab with 2 cycles of chemotherapy versus 4 cycles of chemoth...
European journal of cancer (Oxford, England : 1990) · 2024-11
Nivolumab plus ipilimumab plus twee cycli chemotherapie bij NSCLC: CheckMate 9LA fase III
The Lancet. Oncology · 2021-02
Nivolumab plus ipilimumab versus chemotherapie als eerstelijns bij NSCLC: CheckMate 227 Part 1 OS
European journal of cancer (Oxford, England : 1990) · 2019-07